Featured Content Harrow Health, Inc. (HROW) Harrow Health, Inc. is a pharmaceutical company specializing in the development, production, and sale of compounded medications used in ophthalmology and other medical fields. The company focuses on providing affordable and accessible medications, helping address patient needs in various healthcare settings through its growing portfolio. With a commitment to […]
Read MoreFeatured Content ARS Pharmaceuticals, Inc. (SPRY) is a biopharmaceutical company focused on developing innovative treatments for severe allergic reactions, particularly anaphylaxis. Their flagship product, Neffy, is a nasal spray designed as a convenient and needle-free alternative to epinephrine auto-injectors like EpiPen. Neffy aims to address the needs of patients who suffer from life-threatening allergic reactions […]
Read MoreAssembly Biosciences, Inc. (ASMB) Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases. BridgeBio Pharma, Inc. (BBIO) BridgeBio Pharma, Inc., a commercial-stage biopharmaceutical company, discovers, creates, tests, and delivers transformative medicines to treat patients who suffer from genetic diseases and cancers. Bausch Health Companies Inc. (BHC) Bausch Health Companies Inc. operates as […]
Read MoreSoleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Larimar Therapeutics, Inc. (LRMR) Larimar Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing treatments for rare diseases using its novel cell penetrating peptide technology platform. Summit Therapeutics Inc. (SMMT) Summit Therapeutics […]
Read MoreDyne Therapeutics, Inc. (DYN) is a clinical-stage biotechnology company focused on developing transformative therapeutics for people living with serious muscle diseases caused by genetic mutations. The company is headquartered in Waltham, Massachusetts, and leverages its proprietary FORCE™ platform to create innovative oligonucleotide therapeutics designed to deliver drugs directly to muscle tissue, thereby overcoming significant challenges […]
Read MoreInternational Paper Company (IP) International Paper Company produces and sells renewable fiber-based packaging and pulp products in North America, Latin America, Europe, and North Africa. News Corporation (NWSA) News Corporation, a media and information services company, creates and distributes authoritative and engaging content, and other products and services for consumers and businesses worldwide. Corcept Therapeutics Incorporated (CORT) Corcept […]
Read MoreHeron Therapeutics, Inc. (HRTX) is a biotechnology company focused on improving the lives of patients by developing novel, patient-focused therapeutic solutions. The company specializes in treatments for cancer and pain management. Heron’s key products include Sustol, an extended-release injectable designed to prevent chemotherapy-induced nausea and vomiting (CINV), and Cinvanti, an intravenous formulation that also targets […]
Read MorePerspective Therapeutics, Inc. (CATX) Perspective Therapeutics, Inc., together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. Soleno Therapeutics, Inc. (SLNO) Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Larimar Therapeutics, […]
Read MoreAvadel Pharmaceuticals plc (AVDL) Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Verrica Pharmaceuticals Inc. (VRCA) Verrica Pharmaceuticals Inc., a clinical-stage dermatology therapeutics company, develops medications for the treatment of skin diseases in the United States. JanOne Inc. (JAN) JanOne Inc., a clinical-stage biopharmaceutical company, focuses on identifying, acquiring, licensing, developing, partnering, and commercializing […]
Read MoreGeneration Bio Co. (GBIO) Generation Bio Co. develops non-viral genetic medicines for the treatment of rare and prevalent diseases. Teva Pharmaceutical Industries Limited (TEVA) Teva Pharmaceutical Industries Limited develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, Israel, and internationally. Assembly Biosciences, Inc. (ASMB) Assembly Biosciences, Inc., a biopharmaceutical company, discovers […]
Read MoreBioventus Inc., a medical device company, focuses on developing and commercializing treatments that engage and enhance the body’s natural healing process in the United States and internationally. The company’s product portfolio includes pain treatments, which comprise non-surgical pain injection therapies, as well as peripheral nerve stimulation products, such as Durolane, GELSYN-3, and SUPARTZ for the […]
Read MoreCBIZ, Inc. (CBZ) CBIZ, Inc. provides financial, insurance, and advisory services in the United States and Canada. It operates through Financial Services, Benefits and Insurance Services, and National Practices segments. Intuitive Surgical, Inc. (ISRG) Intuitive Surgical, Inc. develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally […]
Read MoreAbsci Corporation (ABSI) is a biotechnology company that leverages artificial intelligence (AI) and synthetic biology to revolutionize drug discovery and development. Founded in 2011 by Sean McClain, the company is headquartered in Vancouver, Washington. Absci’s mission is to accelerate the development of innovative biologic drugs, which are crucial for treating a wide range of diseases, […]
Read MoreDyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. It develops various programs for myotonic dystrophy type 1, duchenne muscular dystrophy, and facioscapulohumeral dystrophy, as well as rare skeletal muscle, and cardiac and metabolic muscle diseases using its […]
Read MoreFusion Pharmaceuticals Inc., a clinical-stage oncology company, focuses on developing radiopharmaceuticals as precision medicines. Its lead product candidates include FPI-2265 that is in Phase 2 clinical trial to treat prostate-specific membrane antigens; and FPI-1434 that is in Phase 1 clinical trial as a monotherapy in patients with solid tumors expressing insulin-like growth factor 1 receptor. […]
Read More